|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.000 EUR | -1.96% |
|
-1.96% | +3.08% |
| 05-28 | Monbat AD Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-03 | Monbat AD Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.13 | 1.84 | 2.23 | 1.94 | 1.64 | |||||
Return on Total Capital | 1.31 | 2.14 | 2.59 | 2.25 | 1.9 | |||||
Return On Equity % | 1.44 | 3.05 | 4.05 | 2.12 | 2.26 | |||||
Return on Common Equity | 1.42 | 3.45 | 4.41 | 1.57 | 1.21 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 34.29 | 29.9 | 34.16 | 37.73 | 38.31 | |||||
SG&A Margin | 22.34 | 22.57 | 22.76 | 26.13 | 27.65 | |||||
EBITDA Margin % | 7.33 | 8.64 | 9.83 | 9.46 | 8.45 | |||||
EBITA Margin % | 2.23 | 3.8 | 4.73 | 4.08 | 3.43 | |||||
EBIT Margin % | 2.22 | 3.74 | 4.65 | 3.99 | 3.1 | |||||
Income From Continuing Operations Margin % | 0.82 | 1.75 | 2.36 | 1.23 | 1.25 | |||||
Net Income Margin % | 0.8 | 1.21 | 2.79 | 0.67 | 0.5 | |||||
Net Avail. For Common Margin % | 0.8 | 1.91 | 2.41 | 0.84 | 0.62 | |||||
Normalized Net Income Margin | 0.81 | 1.48 | 1.83 | 0.62 | -0.07 | |||||
Levered Free Cash Flow Margin | -2.88 | -8.31 | -0.81 | 8.01 | 7.32 | |||||
Unlevered Free Cash Flow Margin | -1.85 | -6.96 | 1.16 | 10.1 | 8.96 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.79 | 0.77 | 0.78 | 0.85 | |||||
Fixed Assets Turnover | 2.2 | 2.11 | 2.05 | 2.03 | 2.1 | |||||
Receivables Turnover (Average Receivables) | 6 | 3.21 | 4.93 | 5.55 | 7.64 | |||||
Inventory Turnover (Average Inventory) | 2.4 | 2.51 | 2.39 | 2.32 | 2.67 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.62 | 1.54 | 1.4 | 1.27 | 1.3 | |||||
Quick Ratio | 0.63 | 0.75 | 0.53 | 0.5 | 0.51 | |||||
Operating Cash Flow to Current Liabilities | 0.17 | 0.22 | 0.17 | 0.28 | 0.32 | |||||
Days Sales Outstanding (Average Receivables) | 60.85 | 113.78 | 73.99 | 65.97 | 47.75 | |||||
Days Outstanding Inventory (Average Inventory) | 151.95 | 145.6 | 152.51 | 157.56 | 136.76 | |||||
Average Days Payable Outstanding | 44.94 | 49.02 | 52.58 | 60.07 | 60.59 | |||||
Cash Conversion Cycle (Average Days) | 167.86 | 210.35 | 173.92 | 163.46 | 123.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 86.99 | 90.93 | 93.6 | 88.41 | 78.74 | |||||
Total Debt / Total Capital | 46.52 | 47.63 | 48.35 | 46.92 | 44.05 | |||||
LT Debt/Equity | 40.46 | 36.51 | 27.62 | 22.5 | 23.26 | |||||
Long-Term Debt / Total Capital | 21.64 | 19.12 | 14.26 | 11.94 | 13.01 | |||||
Total Liabilities / Total Assets | 54.38 | 55.08 | 55.25 | 53.92 | 51.74 | |||||
EBIT / Interest Expense | 1.34 | 1.72 | 1.47 | 1.19 | 1.19 | |||||
EBITDA / Interest Expense | 4.45 | 4.2 | 3.26 | 3 | 3.46 | |||||
(EBITDA - Capex) / Interest Expense | 1.55 | 1.08 | 1.54 | 1.22 | 1.63 | |||||
Total Debt / EBITDA | 6.67 | 5.9 | 5.35 | 5.15 | 4.86 | |||||
Net Debt / EBITDA | 6.39 | 5.66 | 5.03 | 4.69 | 4.29 | |||||
Total Debt / (EBITDA - Capex) | 19.09 | 22.86 | 11.35 | 12.73 | 10.3 | |||||
Net Debt / (EBITDA - Capex) | 18.29 | 21.94 | 10.67 | 11.59 | 9.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 22.68 | 2.29 | 3.83 | -1.7 | 4.5 | |||||
Gross Profit, 1 Yr. Growth % | 18.9 | -10.84 | 17.26 | 9 | 7.26 | |||||
EBITDA, 1 Yr. Growth % | -11.35 | -23.98 | 14.47 | -3.77 | 8.55 | |||||
EBITA, 1 Yr. Growth % | -26.28 | -43.72 | 21.54 | -13.67 | 29.97 | |||||
EBIT, 1 Yr. Growth % | -26.75 | -44.58 | 21.32 | -14.07 | 21.11 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 184.14 | -67.28 | 29.89 | -54.65 | 276.64 | |||||
Net Income, 1 Yr. Growth % | 132.61 | 51.69 | 136.3 | -59.06 | 165.03 | |||||
Normalized Net Income, 1 Yr. Growth % | 31.16 | -62.26 | 21.48 | -66.22 | -111.08 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 132.61 | -64.28 | 22.12 | -69.6 | 134.91 | |||||
Accounts Receivable, 1 Yr. Growth % | 55.47 | 1.32 | 8.4 | -25.73 | -21.94 | |||||
Inventory, 1 Yr. Growth % | 5.53 | 0.61 | 0.38 | -3.94 | -11.28 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.88 | 11.98 | -0.88 | 3.62 | -0.71 | |||||
Total Assets, 1 Yr. Growth % | 0.58 | 7.51 | 2.22 | -2.94 | -4.28 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.89 | -4.27 | 1.78 | -1.68 | 1.34 | |||||
Common Equity, 1 Yr. Growth % | -1.67 | -0.61 | 2.03 | 1.22 | 0.39 | |||||
Cash From Operations, 1 Yr. Growth % | -23.19 | 53.3 | -11.4 | 48.4 | 3.2 | |||||
Capital Expenditures, 1 Yr. Growth % | 5.8 | 42.63 | -17.65 | 1.13 | -16.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -22.4 | -3.54K | -89.97 | 1.26K | -4.3 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -30.01 | -650.26 | -117.27 | 294.35 | -7.18 | |||||
Dividend Per Share, 1 Yr. Growth % | -21.43 | -27.23 | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.3 | 11.18 | 2.22 | 2.1 | 1.38 | |||||
Gross Profit, 2 Yr. CAGR % | 10.86 | 2.2 | 2 | 14.04 | 7.57 | |||||
EBITDA, 2 Yr. CAGR % | -12.08 | 2.56 | -5.97 | 5.12 | -5.16 | |||||
EBITA, 2 Yr. CAGR % | -32.22 | 12.5 | -15.41 | 2.52 | -12.8 | |||||
EBIT, 2 Yr. CAGR % | -31.97 | 11.53 | -16.1 | 2.26 | -16.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -44.05 | 147.75 | -32.85 | -17.69 | -30.43 | |||||
Net Income, 2 Yr. CAGR % | -49.82 | 87.84 | 89.33 | -24.52 | -43.69 | |||||
Normalized Net Income, 2 Yr. CAGR % | -36.69 | 55.27 | -30.95 | -35.6 | -79.75 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -45.88 | 136.12 | -32.12 | -34.41 | -51.55 | |||||
Accounts Receivable, 2 Yr. CAGR % | 4.2 | 55.64 | -16.6 | -10.95 | -23.86 | |||||
Inventory, 2 Yr. CAGR % | 3.43 | 3.04 | 0.49 | -2 | -8.84 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2.13 | 4.82 | 5.35 | 1.26 | 1.43 | |||||
Total Assets, 2 Yr. CAGR % | -0.63 | 3.99 | 4.83 | -0.56 | -3.86 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.68 | -0.63 | -1.92 | -0.7 | -2.57 | |||||
Common Equity, 2 Yr. CAGR % | -0.65 | -1.14 | 0.7 | 0.35 | 0.36 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.46 | 7.95 | 16.54 | 19.26 | 23.75 | |||||
Capital Expenditures, 2 Yr. CAGR % | -26.74 | 22.85 | 8.38 | -4.76 | -8.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -44.89 | 50.26 | 84.88 | -0.09 | 260.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -58.07 | 62.95 | -2.99 | 22.61 | 91.23 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -24.38 | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.28 | 4.42 | 8.08 | 1.61 | 2.92 | |||||
Gross Profit, 3 Yr. CAGR % | 14.54 | 2.59 | 6.82 | 4.89 | 11.35 | |||||
EBITDA, 3 Yr. CAGR % | 6.6 | -2.84 | 6.95 | -5.14 | 1.08 | |||||
EBITA, 3 Yr. CAGR % | 3.52 | -7.6 | 17.19 | -14.79 | -2.54 | |||||
EBIT, 3 Yr. CAGR % | 3.52 | -7.72 | 16.47 | -15.34 | -5.3 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 72.54 | -12.22 | 103.76 | -38.27 | -10.25 | |||||
Net Income, 3 Yr. CAGR % | 115.18 | -27.44 | 102.78 | -4.75 | -23.86 | |||||
Normalized Net Income, 3 Yr. CAGR % | 53.26 | -9.68 | 44.95 | -45.4 | -63.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 54.99 | -11.12 | 93.02 | -45.45 | -30.74 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.43 | 19.15 | 18.47 | -20.17 | -14.78 | |||||
Inventory, 3 Yr. CAGR % | 7.17 | 2.48 | 2.14 | -1.14 | -5.99 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.35 | 2.36 | 2.88 | 4.71 | 0.6 | |||||
Total Assets, 3 Yr. CAGR % | -0.42 | 2.01 | 3.4 | 2.06 | -1.99 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.42 | -0.57 | -0.26 | -2.32 | -1.63 | |||||
Common Equity, 3 Yr. CAGR % | -3.39 | -0.64 | -0.09 | 0.03 | 0.07 | |||||
Cash From Operations, 3 Yr. CAGR % | 37.12 | 17.54 | 1.07 | 29.67 | 13.65 | |||||
Capital Expenditures, 3 Yr. CAGR % | -4.96 | -8.53 | 7.51 | 8.96 | -8.83 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -38.64 | -4.04 | -39.25 | 224.03 | -1.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -45.6 | -12.63 | -23.14 | 101.57 | 11.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.19 | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.68 | 3.77 | 5.5 | 3.15 | 5.8 | |||||
Gross Profit, 5 Yr. CAGR % | 6.87 | 3.81 | 9.02 | 6.92 | 7.49 | |||||
EBITDA, 5 Yr. CAGR % | -10.18 | -3.68 | 10.83 | 0.59 | 2 | |||||
EBITA, 5 Yr. CAGR % | -24.58 | -11.16 | 19.35 | -2.81 | 4.16 | |||||
EBIT, 5 Yr. CAGR % | -24.65 | -11.43 | 19.06 | -2.96 | 2.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -36.01 | -26.53 | 72.54 | -13.43 | 36.32 | |||||
Net Income, 5 Yr. CAGR % | -35.38 | -31.4 | 104.44 | -26.29 | 9.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | -32.59 | -18.67 | 52.91 | -20.49 | -33.9 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -37.01 | -25.66 | 63.01 | -20.43 | 14.36 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.73 | 11.98 | 1.62 | -3.21 | -1.03 | |||||
Inventory, 5 Yr. CAGR % | 3.73 | 5.5 | 4.45 | 0.67 | -2.48 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.9 | 3.52 | 2.32 | 1.92 | 2.27 | |||||
Total Assets, 5 Yr. CAGR % | 6.48 | 3.72 | 1.65 | 0.97 | 0.36 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.3 | -1.63 | -2.87 | -0.88 | -1.48 | |||||
Common Equity, 5 Yr. CAGR % | 1 | -0.79 | -1.77 | -0.24 | -0.42 | |||||
Cash From Operations, 5 Yr. CAGR % | 19.31 | 7.75 | 28.22 | 18.22 | 11.33 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.8 | 16.23 | 0.17 | -7.04 | 2.72 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -24.07 | 14.33 | -41.81 | -2.67 | 16.36 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -30.26 | 8.51 | -36.35 | -0.14 | 29.66 | |||||
Dividend Per Share, 5 Yr. CAGR % | -12.94 | -11.8 | - | - | - |
- Stock Market
- Stocks
- MONB Stock
- Financials Monbat AD
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















